上海医药：关于溴吡斯的明缓释片获得批准生产的公告

Core Viewpoint - Shanghai Pharmaceuticals has received approval from the National Medical Products Administration for the production of bromperidol sustained-release tablets, indicating a significant advancement in its product portfolio [1] Company Summary - Shanghai Pharmaceuticals announced that its subsidiary, Shanghai Shiyu Chinese and Western Medicine Co., Ltd., has obtained the Drug Registration Certificate for bromperidol sustained-release tablets, with the certificate number 2025S03175 [1]